Search

Home > New FDA Approvals > 089 - Durvalumab for unresectable stage III NSCLC; blue light cystoscopy with Cysview.
Podcast: New FDA Approvals
Episode:

089 - Durvalumab for unresectable stage III NSCLC; blue light cystoscopy with Cysview.
Category: Science & Medicine
Duration: 00:07:37
Publish Date: 2018-02-19 07:00:00
Description:

February 19, 2018

1:16 US FDA approves Imfinzi® (durvalumab) for unresectable stage III non-small cell lung cancer https://www.prnewswire.com/news-releases/fda-expands-approval-of-imfinzi-to-reduce-the-risk-of-non-small-cell-lung-cancer-progressing-300600327.html

https://www.prnewswire.com/news-releases/us-fda-approves-imfinzi-durvalumab-for-unresectable-stage-iii-non-small-cell-lung-cancer-300600414.html 

4:34 Photocure announces U.S. FDA approval of new indication for blue light cystoscopy with Cysview® https://www.prnewswire.com/news-releases/photocure-announces-us-fda-approval-of-new-indication-for-blue-light-cystoscopy-with-cysview-300600062.html

Brought to you by Nascent Medical, http://www.nascentmc.com

Music credit: http://freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0